GPC3 and hepatocellular carcinoma: In hepatocellular carcinoma, the abTCR recognizes alpha-fetoprotein presented by HLA-A*02, while a second chimeric receptor, consisting of a GPC3-specific scFv fused to CD28, delivers additional stimulation [156].